137 related articles for article (PubMed ID: 36305127)
1. Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies.
Molnar M; Lončarić M; Opačak-Bernardi T; Glavaš-Obrovac L; Rastija V
Anticancer Agents Med Chem; 2023; 23(7):839-846. PubMed ID: 36305127
[TBL] [Abstract][Full Text] [Related]
2. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
3. Environmentally Friendly Approach to Knoevenagel Condensation of Rhodanine in Choline Chloride: Urea Deep Eutectic Solvent and QSAR Studies on Their Antioxidant Activity.
Molnar M; Brahmbhatt H; Rastija V; Pavić V; Komar M; Karnaš M; Babić J
Molecules; 2018 Jul; 23(8):. PubMed ID: 30060629
[TBL] [Abstract][Full Text] [Related]
4.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
5. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
6. Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.
Xu JF; Wang TT; Yuan Q; Duan YT; Xu YJ; Lv PC; Wang XM; Yang YS; Zhu HL
Bioorg Med Chem; 2019 Apr; 27(8):1509-1516. PubMed ID: 30846404
[TBL] [Abstract][Full Text] [Related]
7. Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives.
Yin LJ; Bin Ahmad Kamar AKD; Fung GT; Liang CT; Avupati VR
Biomed Pharmacother; 2022 Jan; 145():112406. PubMed ID: 34785416
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization, Antibacterial and Antioxidant Potency of NSubstituted- 2-Sulfanylidene-1,3-Thiazolidin-4-one Derivatives and QSAR Study.
Brahmbhatt H; Molnar M; Pavić V; Rastija V
Med Chem; 2019; 15(8):840-849. PubMed ID: 30520381
[TBL] [Abstract][Full Text] [Related]
9. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
10. Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents.
Akhavan M; Foroughifar N; Pasdar H; Bekhradnia A
Comb Chem High Throughput Screen; 2019; 22(10):716-727. PubMed ID: 31775594
[TBL] [Abstract][Full Text] [Related]
11. Searching for Potential Novel BCR-ABL Tyrosine Kinase Inhibitors Through G-QSAR and Docking Studies of Some Novel 2-Phenazinamine Derivatives.
Kale M; Sonwane G; Choudhari Y
Curr Comput Aided Drug Des; 2020; 16(5):501-510. PubMed ID: 30345925
[TBL] [Abstract][Full Text] [Related]
12. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
Jarapula R; Badavath VN; Rekulapally S; Manda S
Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
[TBL] [Abstract][Full Text] [Related]
13. Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors.
Li SN; Xu YY; Gao JY; Yin HR; Zhang SL; Li HQ
Bioorg Med Chem; 2015 Jul; 23(13):3221-7. PubMed ID: 26003342
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.
Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS
Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents.
Ramesh V; Ananda Rao B; Sharma P; Swarna B; Thummuri D; Srinivas K; Naidu VG; Jayathirtha Rao V
Eur J Med Chem; 2014 Aug; 83():569-80. PubMed ID: 24996143
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Antiproliferative Activity of Novel Neocryptolepine-Rhodanine Hybrids.
El-Bahnsawye M; Hussein MKA; Elmongy EI; Awad HM; Tolan AAE; Moemen YS; El-Shaarawy A; El-Sayed IE
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364427
[TBL] [Abstract][Full Text] [Related]
17. Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs.
Miladiyah I; Jumina J; Haryana SM; Mustofa M
Drug Des Devel Ther; 2018; 12():149-158. PubMed ID: 29391779
[TBL] [Abstract][Full Text] [Related]
18. QSAR and molecular docking studies of lethal factor protease inhibitors against
Saxena M; Nandi S; Saxena AK
SAR QSAR Environ Res; 2019 Oct; 30(10):715-731. PubMed ID: 31556709
[No Abstract] [Full Text] [Related]
19. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity assessment, QSAR and docking study of novel bis-carboxamide derivatives of 4-pyrones synthesized by Ugi four-component reaction.
Shahrisa A; Esmati S; Miri R; Firuzi O; Edraki N; Nejati M
Eur J Med Chem; 2013 Aug; 66():388-99. PubMed ID: 23827179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
